Dianthus Therapeutics, Inc. (DNTH) — QMA analysis
Sector: Healthcare · Market cap: $1.9B · Price: $78,53 · Data as of 2026-10-22
Dianthus Therapeutics, Inc. has a below-average composite score of 43/100, higher score than 48% of 22,733 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Insider activity.
What 12 data layers say about DNTH
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 50/100 |
| Earnings quality (EQS) | 40/100 |
| Technical trend (TSS) | 48/100 |
| Relative strength (RS) | 41/100 |
| Momentum (USS) | 42/100 |
| Insider activity (IAS) | 16/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 55/100 |
| Institutional 13F (IFS) | 65/100 |
| Options flow (OFS) | 74/100 |
| News sentiment (NSS) | 54/100 |
| Analysts / transcripts (ATS) | 81/100 |
| Catalysts (XS) | 19/100 |
What does the QMA model currently show for Dianthus Therapeutics, Inc.?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For DNTH the layers diverge — some score high (Analysts / transcripts), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
DNTH insider & smart money activity
Over the recent period we record 14 reported insider purchases and 45 sales for DNTH: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.
DNTH seasonality
The historically strong window for DNTH was July 1–28 with a hit rate of 67% and an average move of 3.0% (9 years of history).
Historical data does not guarantee future results.
How DNTH compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for DNTH stock?
43/100 (D) — Data as of 2026-10-22.
Are insiders buying DNTH stock?
Over the recent period, reported: purchases 14, sales 45 (purchases $3.75M, sales $32.7M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.
Where can I see live DNTH data?
Live DNTH data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]